These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36119648)

  • 41. Neuropsychiatric manifestations of COVID-19, potential neurotropic mechanisms, and therapeutic interventions.
    Han Y; Yuan K; Wang Z; Liu WJ; Lu ZA; Liu L; Shi L; Yan W; Yuan JL; Li JL; Shi J; Liu ZC; Wang GH; Kosten T; Bao YP; Lu L
    Transl Psychiatry; 2021 Sep; 11(1):499. PubMed ID: 34593760
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The chronic neuropsychiatric sequelae of COVID-19: The need for a prospective study of viral impact on brain functioning.
    de Erausquin GA; Snyder H; Carrillo M; Hosseini AA; Brugha TS; Seshadri S;
    Alzheimers Dement; 2021 Jun; 17(6):1056-1065. PubMed ID: 33399270
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SARS-Cov-2 Damage on the Nervous System and Mental Health.
    Boulkrane MS; Ilina V; Melchakov R; Arisov M; Fedotova J; Gozzo L; Drago F; Lu W; Sarapultsev A; Tseilikman V; Baranenko D
    Curr Neuropharmacol; 2022; 20(2):412-431. PubMed ID: 34191699
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of intensive care unit-specific virtual reality (ICU-VR) to improve psychological well-being and quality of life in COVID-19 ICU survivors: a study protocol for a multicentre, randomized controlled trial.
    Vlake JH; Van Bommel J; Wils EJ; Korevaar TIM; Hellemons ME; Schut AFC; Labout JAM; Schreuder LLH; Gommers D; Van Genderen ME
    Trials; 2021 May; 22(1):328. PubMed ID: 33952318
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acute and Post-Acute Neurological Complications of COVID-19.
    Al-Ramadan A; Rabab'h O; Shah J; Gharaibeh A
    Neurol Int; 2021 Mar; 13(1):102-119. PubMed ID: 33803475
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Radiological Manifestation of Neurological Complications in the Course of SARS-CoV-2 Infection.
    Sklinda K; Dorobek M; Wasilewski PG; Dreżewski K; Dȩbicka M; Walecki J; Mruk B
    Front Neurol; 2021; 12():711026. PubMed ID: 34744963
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Experimental Models of SARS-COV-2 Infection in the Central Nervous System.
    Paoletti AM; Melilli MG; Vecchio I
    J Cent Nerv Syst Dis; 2022; 14():11795735221102231. PubMed ID: 35783991
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19).
    Harapan BN; Yoo HJ
    J Neurol; 2021 Sep; 268(9):3059-3071. PubMed ID: 33486564
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protocol of the Luebeck longitudinal investigation of SARS-CoV-2 infection (ELISA) study - a prospective population-based cohort study.
    Balck A; Föh B; Borsche M; Rahmöller J; Vollstedt EJ; Waldeck F; Käding N; Twesten C; Mischnik A; Gillessen-Kaesbach G; Ehlers M; Sina C; Taube S; Busch H; Rupp J; Katalinic A; Klein C
    BMC Public Health; 2022 Jul; 22(1):1305. PubMed ID: 35799167
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SARS-CoV-2 Emergency and Long-Term Cognitive Impairment in Older People.
    Rizzo MR; Paolisso G
    Aging Dis; 2021 Apr; 12(2):345-352. PubMed ID: 33815868
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuropsychiatric manifestations of COVID-19 and possible pathogenic mechanisms: Insights from other coronaviruses.
    Banerjee D; Viswanath B
    Asian J Psychiatr; 2020 Dec; 54():102350. PubMed ID: 33271682
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Psychiatric sequelae in COVID-19 survivors: A narrative review.
    Putri C; Arisa J; Hananto JE; Hariyanto TI; Kurniawan A
    World J Psychiatry; 2021 Oct; 11(10):821-829. PubMed ID: 34733644
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Direct neuronal infection of SARS-CoV-2 reveals cellular and molecular pathology of chemosensory impairment of COVID-19 patients.
    Lyoo KS; Kim HM; Lee B; Che YH; Kim SJ; Song D; Hwang W; Lee S; Park JH; Na W; Yun SP; Kim YJ
    Emerg Microbes Infect; 2022 Dec; 11(1):406-411. PubMed ID: 34962444
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cognitive and Neuropsychiatric Manifestations of COVID-19 and Effects on Elderly Individuals With Dementia.
    Alonso-Lana S; Marquié M; Ruiz A; Boada M
    Front Aging Neurosci; 2020; 12():588872. PubMed ID: 33192483
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Musculoskeletal Consequences of COVID-19.
    Disser NP; De Micheli AJ; Schonk MM; Konnaris MA; Piacentini AN; Edon DL; Toresdahl BG; Rodeo SA; Casey EK; Mendias CL
    J Bone Joint Surg Am; 2020 Jul; 102(14):1197-1204. PubMed ID: 32675661
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Microglial Implications in SARS-CoV-2 Infection and COVID-19: Lessons From Viral RNA Neurotropism and Possible Relevance to Parkinson's Disease.
    Awogbindin IO; Ben-Azu B; Olusola BA; Akinluyi ET; Adeniyi PA; Di Paolo T; Tremblay MÈ
    Front Cell Neurosci; 2021; 15():670298. PubMed ID: 34211370
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of SARS-CoV-2 Infection on Attention, Memory, and Sensorimotor Performance.
    O'Connor EE; Rednam N; O'Brien R; O'Brien S; Rock P; Levine A; Zeffiro TA
    medRxiv; 2022 Sep; ():. PubMed ID: 36172134
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neurological manifestations of coronavirus infections, before and after COVID-19: a review of animal studies.
    Bakhtazad A; Garmabi B; Joghataei MT
    J Neurovirol; 2021 Dec; 27(6):864-884. PubMed ID: 34727365
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The need for holistic, longitudinal and comparable, real-time assessment of the emotional, behavioral and societal impact of the COVID-19 pandemic across nations.
    Agorastos A; Tsamakis K; Solmi M; Correll CU; Bozikas VP
    Psychiatriki; 2021 Apr; 32(1):15-18. PubMed ID: 33759804
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Persistent cognitive impairment associated with cerebrospinal fluid anti-SARS-CoV-2 antibodies six months after mild COVID-19.
    Borsche M; Reichel D; Fellbrich A; Lixenfeld AS; Rahmöller J; Vollstedt EJ; Föh B; Balck A; Klein C; Ehlers M; Moser A
    Neurol Res Pract; 2021 Jun; 3(1):34. PubMed ID: 34148546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.